Condition
Cancer Related Cardiovascular Toxicity clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Cancer Related Cardiovascular Toxicity clinical trials that are recruiting, at sites in 4 countries (most in Italy (1), North Macedonia (1), Serbia (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 4Countries
All recruiting trials (2)
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
-
Registry to detect and prevent cancer-related heart damage
This registry tries to track heart problems caused by cancer treatments and validate a risk score in adults with cancer, focusing on newly diagnosed breast cancer patients receiving anthracyclines.
Related topics
Quick answers
How many Cancer Related Cardiovascular Toxicity clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (1 trial), North Macedonia (1 trial), Serbia (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.